Angel Physicians Fund
Angel networkSeed–Series A · 5 people tracked
Find your way into Angel Physicians Fund
2,685 people in our graph share verified history with the Angel Physicians Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Angel Physicians Fund invests in healthcare startups, prioritizing capital-efficient companies with strong valuation growth potential and academic or university backing. It favors ventures at the clinical development stage over pure technology development and looks for opportunities with global impact. Members frequently join portfolio company boards or scientific advisory panels, contributing clinical insight, help with clinical trial protocols, cost-of-care and reimbursement studies, and access to academic, corporate, and financial networks. The fund's dual mission is to expand the availability of clinical tools in the market while delivering strong returns to its investors, taking an active, hands-on role in accelerating portfolio company growth.
Source: firm website, verified Aug 7, 2026.
Team · 5 people
from public directories
.avif)
What they invest in
from 36 of 45 portfolio companiesHealthtech ×30Medical Devices ×25Biotech ×18AI & Machine Learning ×7Digital Health ×7Deep Tech ×4Advanced Manufacturing ×2Hardware ×2
HQs:United States×26
Who they back
founder profiles across 19 portfolio companiesFounding team size:solo founder×102 founders×53 founders×34+ founders×1
Where their founders studiedfrom 20 founders with education data
Stanford University School of Medicine ×3Massachusetts Institute of Technology ×2Stanford University ×2Tufts University ×2UCLA ×2University of Michigan College of Engineering ×2University of Oklahoma ×2
Where their founders worked beforefrom 21 founders with career history
Memorial Sloan-Kettering Cancer Center ×2
Accelerator rootsportfolio companies that came through a program
5 founders hold a PhD · 1 hold an MBA (of 20 with degree data)
Investments · 45 tracked
founders shown can be your intro pathBy year:2025 · 12019 · 12018 · 12017 · 14 dated
Alphyn Biologics develops Multi-Target Therapeutics based on its Zabalafin (AB-101) platform to treat skin diseases, with a lead candidate, zabalafin hydrogel, a non-steroidal topical treatment for atopic dermatitis in children and adults that targets itch, inflammation, and Staph bacteria.
BiotechHealthtechMedical DevicesAnnapolis, US
Jazmyne Mink(Co-founder & Regulatory Affairs Director)inGary Pekoe(Co-founder & Chief Scientific Officer)Neal Koller(Co-founder & CEO, Chairman of the Board)Steven Pentelnik(Co-founder & President)
Co-investorsQCA First
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)
Co-investorsBrightstone Venture CapitalBroadview VenturesPortfoliaCatalyst Health VenturesXeraya Capital
ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged.
BiotechDeep TechHealthtechDavis, US
Brad Niles(Chief Executive Officer)Glenn Kazo(Chief Business Officer)
BoardLonnie Bookbinder(Board Chairman)
Co-investorsMoneta Ventures
Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
BiotechMedical Devices
Co-investorsCincyTech
Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest.
Digital HealthHealthtechIoTMedical DevicesForsyth, US
Rory Beyer(Co-founder)inMoseley Andrews(Co-founder)inSameer Jafri(Co-founder)in
Co-investorsHealthtech CapitalIrishAngelsLaerdal Million Lives FundQuesta CapitalRC CapitalCatalyst Health Ventures+1 more
Banjo Health builds AI-driven software to automate and streamline the prior authorization process for health plans and pharmacy benefit managers (PBMs).
AI & Machine LearningDigital HealthHealthtechWashington, US
Saaransh Mahna(Executive Officer, Director, Promoter)
BoardGregory Epstein(Director)
Co-investorsEpsilon Health InvestorsTau VenturesTAU Ventures
Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.
BiotechMedical Devices
Charles Sidoti(Founder)in
Co-investorsExcelestar VenturesFemHealth VenturesSchooner CapitalSV Health Investors
Clint operates a clinical decision support platform that matches patients with evidence-based therapies by analyzing electronic health records and clinical guidelines at the point of care.
AI & Machine LearningDigital HealthHealthtechStanford, US
Co-investorsMedMountain Ventures
HealthtechNashua, US
Aaron V. Kaplan, MD(Executive Officer, Director)Aaron V. Kaplan(Executive Officer, Director)inAndy H. Levine(Executive Officer, Director)inJames Reinstein(Executive Officer, Director)in
BoardJoshua Phillips(Director)Scott Ward(Director)
Co-investorsExcelestar Ventures
Conkay Medical is a medical device company developing technologies focused on cardiovascular care.
HealthtechMedical Devices
Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US
Ryan Dittamore(CEO)in
Co-investorsBeresford VenturesCreative Destruction Lab (CDL)Shanda GroupSmartGateVCSonder Capital
Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAphelion CapitalBlueStone Venture Partners
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases.
BiotechHealthtechMedical DevicesCincinnati, US
Mike Hooven(Chairman, President and CEO)inTimothy Flaherty(Executive Officer)Simone Song(Director)Karen Robards(Director)Richard J D'Augustine(Director)Norman R. Weldon(Director)
Co-investorsCincyTechLightship CapitalOhio Innovation FundMagnetar AI VenturesVersant Ventures
Epitel is a digital health company that builds REMI, a wearable, wireless cloud-based EEG monitoring system with AI-based seizure event detection for use in healthcare and ambulatory settings.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSalt Lake City, US
Mark Lehmkuhle(CTO, Founder)inSteve Pacelli(CEO)in
Co-investorsGenoa VenturesOSF VenturesMedMountain VenturesWavemaker Three-Sixty Health
Co-investors4impact capitalAct Venture CapitalACT Venture CapitalAmadeus Capital SAAnkur CapitalArc Angels+65 more
Stealth-mode medical technology company.
CHV is a venture capital firm that invests in medical technology companies developing therapeutic devices, diagnostic tools, and digital health solutions to improve patient outcomes.
HealthtechMedical Devices
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Co-investorsKairos Venture Investments, LlcMemorialCare Innovation FundKairos Venture Partners
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company developing immune therapies for immune-excluded tumors, which resist standard PD-1 blockade.
BiotechHealthtechMedical DevicesDoylestown, US
Michael A. Curran(Director)inJennifer Barlow(Executive Officer, Director)Clifford Stocks(Director)James Barlow(Executive Officer, Director)Jeremy Barton(Executive Officer)Federica O'Brien(Executive Officer)
Co-investorsAdit Ventures Management, LlcService Provider CapitalTexas HALO Fund
Instylla develops resorbable liquid embolic agents for interventional radiology and oncology, including the Embrace Hydrogel Embolic System and the Tembo Embolic System used to embolize hypervascular tumors and occlude peripheral blood vessels.
BiotechHealthtechMedical DevicesBedford, US
Amarpreet Sawhney(Executive Officer)Raymond Lareau(Executive Officer)inSteven Cagnetta(Executive Officer)Sean Boyle(Chief Executive Officer)in
BoardHenry Chen(Director)inTasneem Dohadwala(Director)in
Co-investorsAscension VenturesDelos CapitalExcelestar Ventures
Co-investorsCincyTech
Therapeutics company with an active clinical development program.
The University of Minnesota is a public higher education institution offering undergraduate majors, graduate and professional degrees, and internship and research opportunities across fields including liberal arts and business.
EdTechMinneapolis, US
Co-investorsTraction Capital
MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy.
Advanced ManufacturingHardwareHealthtechMedical DevicesBrecksville, US
Vedang Kothari(President)Sam Shelnutt(Vice-President of Engineering)inMichael Marotta(Vice President of Clinical Affairs)inPeter Broer(Director)Creighton Murch(Director)Austin Ruhle(Chief Financial Officer)
Co-investorsBand of AngelsJumpstart Ventures
Developing photodynamic therapy to enhance cancer care; obtained FDA breakthrough device status.
OrisDX develops a non-invasive salivary-rinse DNA test called Oro Lesion to detect early markers of oral cavity squamous cell carcinoma in adults with indeterminate oral lesions.
BiotechDigital HealthMedical DevicesChicago, US
Harald Steltzer(Executive Officer, Director)inPatrick Conniff(Executive Officer)inEvgeny Izmchenko(Director)Nishant Agrawal(Director)in
Co-investorsHARPER COURT VENTURES
PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects.
BiotechHealthtechMedical DevicesAustin, US
Laura Indolfi(Chief Executive Officer and Co-Founder)inElazer Edelman(Director)
BoardD Mackey(Director)inDaniel Wildman(Director)Darshana Zaveri(Director)Maria Palasis(Director)
Co-investorsCatalyst Health VenturesMission BiocapitalWalnut Venture Associates
This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAdvance Venture PartnersAvestria VenturesAviv Venture CapitalBIGR VenturesBlue Venture FundsBuoyant Ventures Management, Llc+15 more
Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.
AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US
Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)inAlex Furleigh(Chief of Staff)in
Co-investorsDIANecessary VenturesTSVCY CombinatorKdT Ventures
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.
BiotechHardwareHealthtechMedical DevicesOakland, US
Amit Vohra(Executive Officer, Director)inMichael Bartholomew(Executive Officer, Director)inDinesh Kumar(Executive Officer)in
BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)
Co-investorsBand of AngelsFrontier Path VCZynext Ventures
Co-investorsSteelSky Ventures
S4 Medical develops the esolution device, a technology intended to protect the esophagus from ablation energy during cardiac ablation procedures.
HealthtechMedical Devices
Bill Fuller(CEO and Co-founder)inEmile Daoud(Co-founder, Chief Medical Officer, and Co-inventor)in
Co-investorsJumpstart VenturesOhio Innovation Fund
Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault.
Deep TechHealthtechMedical Devices
George "Chip" Shaw(Co-founder)
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)inRick Pendergraft(Co-founder & Chief Technology Officer)inDr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Co-investorsPathway BioventuresPlains Ventures
Spect provides automated retinal screening to detect conditions like diabetic retinopathy and glaucoma in primary care settings, reducing the need for manual assessment by eye specialists.
AI & Machine LearningHealthtechWellness & FitnessSan Francisco, US
Ankur Gupta(Founder/CEO)inRishab Gargeya(Founder)inTed Leng(Founder)in
Co-investorsTaver CapitalY Combinator
Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials.
BiotechEnterprise SoftwareHealthtechMedical Devices
Dave Dingott(CEO and Founder)in
Co-investorsElevate Ventures
Tombot creates animatronic robotic pets designed to provide companionship and therapeutic benefits for people who cannot care for live animals, with initial focus on treating behavioral and psychological symptoms in older adults with dementia.
HealthtechMedical DevicesMental HealthRoboticsValencia, US
Tom Stevens(CEO and Co-Founder)in
Co-investorsCaduceus Capital PartnersWavemaker Three-Sixty Health
TPA Stream provides invoicing software for benefits and medical third-party administrators (TPAs), consolidating scattered billing and admin data into employer invoices using existing systems.
HealthtechInsurTechSaaSShaker Heights, US
Jacob Sheridan(Executive Officer, Director)Stephen Fuhry(Founder)inEric Sukalac(Executive Officer, Director)
BoardBill Fisher(Director)Mark Peterson(Director)Clay Rankin(Director)
Co-investorsJumpstart VenturesService Provider CapitalTamiami Angel
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsBerkeley CatalystExSight VenturesFirst Spark Ventures, LlcPandect BioventuresExSight
VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance.
BiotechDeep TechHealthtech
Sonia Sequeira(Founder & Chief Executive Officer (CEO))inMahiuddin Ahmed(President & Chief Scientific Officer (CSO))in
Portfolio news
latest coverage across their companiesPentec Health Celebrates 35th Anniversary · techcrunch.com · Jul 17, 2026
Tombot · labusinessjournal.com · Jul 13, 2026
Epitel · frontlines.io · Nov 6, 2025
Conformal Medical · finance.yahoo.com · Aug 13, 2025
Frequently asked questions
- How many investments has Angel Physicians Fund made?
- Angel Physicians Fund has 45 tracked investments, including 1 dated in the last 24 months.
- What stage does Angel Physicians Fund invest at?
- Angel Physicians Fund invests at the Seed, Series A stages.
- What sectors does Angel Physicians Fund focus on?
- Angel Physicians Fund focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Does Angel Physicians Fund lead rounds?
- Yes, Angel Physicians Fund leads investment rounds.
- Who does Angel Physicians Fund co-invest with?
- Angel Physicians Fund most often shares deals with CincyTech, Excelestar Ventures, Jumpstart Ventures, among 77 tracked co-investors.
Images
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
JLS Fund is a venture capital firm founded in 2019 that invests in precision neuromedicine, backing companies translating advances in neuroscience, technology, and data into patient outcomes.